Disease Info Card

Congenital Heart Block

Information about Congenital Heart Block: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Congenital Heart Block

Most recent studies have shown that Congenital Heart Block shares some biological mechanisms with atrioventricular-block, autoimmune-diseases, autoimmune-reaction, autoimmunity, bradycardia, cardiac-arrhythmia, cardiomyopathies, complete-atrioventricular-block, congenital-complete-heart-block, congenital-heart-defects, connective-tissue-diseases, exanthema, fetal-diseases, heart-block, heart-diseases, lupus-erythematosus-cutaneous, lupus-erythematosus-systemic, neonatal-lupus-erythematosus, pregnancy-complications, sjogrens-syndrome.

Among the many pathways, these few ones have gauged particular interests from scientists studying Congenital Heart Block, and have been seen in publications frequently: Cardiac Conduction, Cell Activation, Cytokine Production, Developmental Process, Fertilization, Immune Response, Induction Of Apoptosis, Inflammatory Response, Localization, Membrane Repolarization, Opsonization, Parturition, Pathogenesis, Phagocytosis, Proteolysis, Secretion, T Cell Activation, Transdifferentiation, Transport, Transposition

Quite a number of genes have been found to play important roles in Congenital Heart Block, such as ARFGEF1, ARID2, ASCC3, C4A, CALR, CUX1, FUT3, HPS4, HTR4, NDUFA2, PGR, RFC2, SSB, TMEM37, TNF, TRIM21. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.